CN1235608C - Medicine for curing prostatosis and its preparation method - Google Patents

Medicine for curing prostatosis and its preparation method Download PDF

Info

Publication number
CN1235608C
CN1235608C CNB031176143A CN03117614A CN1235608C CN 1235608 C CN1235608 C CN 1235608C CN B031176143 A CNB031176143 A CN B031176143A CN 03117614 A CN03117614 A CN 03117614A CN 1235608 C CN1235608 C CN 1235608C
Authority
CN
China
Prior art keywords
medicine
extractum
gryllotalpa
prostatic hyperplasia
urinary system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
CNB031176143A
Other languages
Chinese (zh)
Other versions
CN1476877A (en
Inventor
刘伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TAIHE PHARMACEUTICAL CO Ltd GUIZHOU
Original Assignee
TAIHE PHARMACEUTICAL CO Ltd GUIZHOU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34152688&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN1235608(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by TAIHE PHARMACEUTICAL CO Ltd GUIZHOU filed Critical TAIHE PHARMACEUTICAL CO Ltd GUIZHOU
Priority to CNB031176143A priority Critical patent/CN1235608C/en
Publication of CN1476877A publication Critical patent/CN1476877A/en
Application granted granted Critical
Publication of CN1235608C publication Critical patent/CN1235608C/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention discloses medicine for treating prostatosis and a preparation method thereof. The medicine is composed of medicine of maidenhair, mole cricket, hedgehog hide, etc. The present invention has the preparation method that hedgehog hide and mole cricket are respectively processed, pulverized, sterilized and pulverized to fine powder. The maidenhair is extracted and concentrated to extractum by a water extraction method or an ethanol extraction method; after fine powder and extractum are mixed, the fine powder and the extractum are made into a required dosage form according to a conventional technique. The obtained medicine has the efficiency of clearing away heat, promoting diuresis, promoting blood circulation for removing blood stasis, promoting the restoration of consciousness and promoting urination. The present invention has the significant curative effect for prostatitis, hyperplasia of prostate and urinary infection.

Description

The medicine and the method for making of treatment prostatitis, prostatic hyperplasia, urinary system infection
Technical field: the present invention is the medicine and the method for making of treatment prostatitis, prostatic hyperplasia, urinary system infection, belongs to technical field of medicaments.
Background technology: prostatosis is the common a kind of disease of male, relatively seriously influences patient's operate as normal and life, and at present, existing treatment generally adopts the method for oral Chinese medicine or Western medicine to treat; The instant effect of Western medicine, but its side effect is more intense, the patient can suffer damage, in addition since drug price than higher, so patient's ability to bear is also more limited; Some enterprises of China utilize traditional Chinese medicine technology to produce some Chinese medicine preparation, and these medicines have some curative effects for the treatment of prostatosis, but effect is imprecise, the prescription more complicated of its medical material of while, and production technology is also numerous and diverse.
Summary of the invention: the objective of the invention is: according to the traditional proved recipe handed down from one's ancestors of China's Guizhou Province's ethnic groups, a kind of have eliminating damp-heat, blood circulation promoting and blood stasis dispelling, sensible diuresis function are provided, be used for the treatment of medicine of prostatitis, prostatic hyperplasia, urinary system infection and preparation method thereof, this medicine is a raw material with a spot of Chinese herbal medicine, utilize the production technology of existing medicine, production can be treated the medicine of prostatosis, to overcome the deficiencies in the prior art.
The present invention constitutes like this: the medicine of treatment prostatosis, and it is to be made by the raw material of following prescription: Herba Adianti 1000-1200, Gryllotalpa 40-80 and Corium Erinacei Seu Hemiechianus 80-120; Also can add Spina Gleditsiae and Semen Vaccariae therein, to strengthen the curative effect of medicine; Specifically: according to weight proportion: it is made into by Herba Adianti 1000-1200, Gryllotalpa 40-80, Corium Erinacei Seu Hemiechianus 80-120, Spina Gleditsiae 400-600 and Semen Vaccariae 80-120; Weight proportion is Herba Adianti 1000, Gryllotalpa 60, Corium Erinacei Seu Hemiechianus 100, Spina Gleditsiae 500 and Semen Vaccariae 100 more accurately; The said medicine of this product is a said dosage form on any pharmaceutics; Certainly, specifically: said dosage form is granule, tablet or capsule.The preparation method of the medicine of this treatment prostatosis is: according to given ratio Herba Adianti 1000-1200, Gryllotalpa 40-80 and Corium Erinacei Seu Hemiechianus 80-120, earlier respectively with Corium Erinacei Seu Hemiechianus, Gryllotalpa, concoct, pulverize, sterilize, be ground into 100 purpose fine powders, the Herba Adianti water carried or extractum is extracted, is condensed into to the method for alcohol extraction, again will fine powder and extractum mix the back and be made into the dosage form that needs according to routine techniques; Specifically: after having added Spina Gleditsiae and Semen Vaccariae, can respectively 100 purpose fine powders be concocted, be pulverized, sterilize, be ground into to Corium Erinacei Seu Hemiechianus, Gryllotalpa, Semen Vaccariae, Herba Adianti, Spina Gleditsiae water heating extraction are condensed into extractum, again with the fine powder that obtains and extractum in described ratio: Herba Adianti 1000-1200, Gryllotalpa 40-80,
Corium Erinacei Seu Hemiechianus 80-120, Spina Gleditsiae 400-600 and Semen Vaccariae 80-120 are mixed and made into 20-60 order granule, make granule or fine powder and extractum are made 40-60 order granule in described ratio, add adjuvant after tabletting is made tablet, also fine powder and extractum can be made 20-40 order granule in described ratio, make capsule through capsule charge; Disinfecting action in the inventive method be with the medicated powder after pulverizing 115 ℃ of following saturated vapors sterilizations 30-40 minute, 121 ℃ of following saturated vapors sterilizations 15-20 minute or 130 ℃ of following saturated vapors sterilizations 8-15 minute, also can adopt other method sterilization.As: irradiation, microwave, gaseous sterilization.Owing to adopted technique scheme, medicine of the present invention that the effect of clearing away heat-damp and promoting diuresis, blood circulation promoting and blood stasis dispelling, sensible diuresis is arranged, prostatitis, prostatic hyperplasia, urinary system infection had obvious therapeutic action.Among the present invention, Herba Adianti is cold, and is lightly seasoned, goes into hot warp, the tool heat-clearing and toxic substances removing, and inducing diuresis to remove edema is principal agent; Gryllotalpa property is cold, and salty in the mouth is gone into hot warp, tool diuresis, function of detoxification; Spina Gleditsiae is hot in nature, and acrid in the mouth is gone into cold warp, tool promoting blood circulation and detumescence, evacuation of pus, and anti-its medicine of holding concurrently is supercool; Semen Vaccariae is cold, and bitter in the mouth is gone into hot warp, tool detumescence promoting blood circulation; Corium Erinacei Seu Hemiechianus property is cold, and bitter in the mouth is gone into hot warp, and the tool stasis-dispelling and pain-killing is the shop medicine altogether, and all medicines share, and eliminating damp-heat is arranged, blood circulation promoting and blood stasis dispelling, the sensible effect that must urinate.
The specific embodiment:
Embodiments of the invention 1: respectively 100 purpose fine powders are concocted, pulverize, sterilize, are ground into to Corium Erinacei Seu Hemiechianus 80 grams, Gryllotalpa 40 grams earlier, extractum is extracted, is condensed into to the method that Herba Adianti 1000 gram waters are carried, again will fine powder and extractum mix the back and be made into capsule according to routine techniques, disinfecting action is 115 ℃ of following saturated vapors sterilizations 30-40 minute, 121 ℃ of following saturated vapors sterilizations 15-20 minute or 130 ℃ of following saturated vapors sterilizations 8-15 minute with the medicated powder after pulverizing.This medicine is oral, and one says three times, one time 6.
Embodiments of the invention 2: respectively 100 purpose fine powders are concocted, pulverize, sterilize, are ground into to Corium Erinacei Seu Hemiechianus 120 grams, Gryllotalpa 80 grams earlier, Herba Adianti 1200 grams are extracted, are condensed into extractum with the method for alcohol extraction, again fine powder and extractum mixing back are made into granule according to routine techniques, disinfecting action adopts irradiation sterilization.
Embodiments of the invention 3: respectively 100 purpose fine powders are concocted, pulverized, sterilize, are ground into to Corium Erinacei Seu Hemiechianus 100 grams, Gryllotalpa 60 grams, Semen Vaccariae 100 grams, Herba Adianti 1000 grams, Spina Gleditsiae 500 gram water heating extraction are condensed into extractum, again fine powder and the extractum that obtains is mixed and made into 40-60 order granule, add adjuvant after tabletting is made tablet, disinfecting action adopts microwave sterilizating.
Seedling medical knowledge opinion thinks, because blood or worn with age or insobriety are scurried in the pyretic toxicity internal resistance, causes the failure of human body blood and slime, and blood vessels are not smooth, water channel unsmooth and take place urine drip drench obstructed; The pyretic toxicity tenesmus then frequent micturition or when urine puckery pain.According to Seedling medical knowledge opinion, all belong to calentura, by the principle of " calentura is cold to be controlled ", should be the rule of treatment with clearing away heat-damp and promoting diuresis, blood circulation promoting and blood stasis dispelling, sensible diuresis, so this side is arranged.Pharmacodynamic study of the present invention shows: 1, the capillary permeability increase of glacial acetic acid induced mice abdominal cavity is had the obvious suppression effect, show that this product has inhibitory action to aseptic inflammation.2, xylol induced mice auricle edema has obvious detumescence effect, shows that this product has antiinflammatory action.3, staphylococcus aureus, Diplococcus gonorrhoeae, kerekou pneumonia pool Salmonella, mycoplasma, colon bacillus and Candida albicans are had significantly antibacterial and bactericidal action, and above-mentioned germ prostatitis and urinary system infection are had therapeutical effect.

Claims (8)

1, a kind of medicine for the treatment of prostatitis, prostatic hyperplasia, urinary system infection is characterized in that: according to weight proportion, it is made by following raw material: Herba Adianti 1000-1200, Gryllotalpa 40-80 and Corium Erinacei Seu Hemiechianus 80-120.
2, according to the medicine of the described treatment prostatitis of claim 1, prostatic hyperplasia, urinary system infection, it is characterized in that: according to weight proportion: it is made into by Herba Adianti 1000-1200, Gryllotalpa 40-80, Corium Erinacei Seu Hemiechianus 80-120, Spina Gleditsiae 400-600 and Semen Vaccariae 80-120.
3, according to the medicine of claim 1 or 2 described treatment prostatitis, prostatic hyperplasia, urinary system infection, it is characterized in that: wherein the weight proportion of each raw material is Herba Adianti 1000, Gryllotalpa 60, Corium Erinacei Seu Hemiechianus 100, Spina Gleditsiae 500 and Semen Vaccariae 100.
4, according to the medicine of claim 1 or 2 described treatment prostatitis, prostatic hyperplasia, urinary system infection, it is characterized in that: said medicament is granule, tablet or capsule.
5, according to the medicine of the described treatment prostatitis of claim 3, prostatic hyperplasia, urinary system infection, it is characterized in that: said medicament is granule, tablet or capsule.
6, the method for making of the medicine of treatment prostatitis, prostatic hyperplasia, urinary system infection, it is characterized in that: get Herba Adianti 1000-1200, Gryllotalpa 40-80 and Corium Erinacei Seu Hemiechianus 80-120 according to weight proportion, earlier respectively with Corium Erinacei Seu Hemiechianus, Gryllotalpa, concoct, pulverize, sterilize, be ground into 100 purpose fine powders, the Herba Adianti water carried or extractum is extracted, is condensed into to the method for alcohol extraction, again will fine powder and extractum mix the back and be made into the dosage form that needs according to routine techniques.
7, according to the described treatment prostatitis of claim 6, prostatic hyperplasia, the method for making of the medicine of urinary system infection, it is characterized in that: respectively with Corium Erinacei Seu Hemiechianus, Gryllotalpa and Semen Vaccariae are concocted, pulverize, sterilization, be ground into 100 purpose fine powders, with Herba Adianti, Spina Gleditsiae water heating extraction is condensed into extractum, again with the fine powder that obtains and extractum in described ratio: Herba Adianti 1000-1200, Gryllotalpa 40-80, Corium Erinacei Seu Hemiechianus 80-120, Spina Gleditsiae 400-600 and Semen Vaccariae 80-120 are mixed and made into 20-60 order granule, make granule or fine powder and extractum are made 40-60 order granule in described ratio, add adjuvant after tabletting is made tablet, fine powder and extractum are made 20-40 order granule in described ratio, make capsule through capsule charge.
8, according to the method for making of the medicine of claim 6 or 7 described treatment prostatitis, prostatic hyperplasia, urinary system infection, it is characterized in that: disinfecting action wherein be with the medicated powder after pulverizing 115 ℃ of following saturated vapors sterilizations 30-40 minute, 121 ℃ of following saturated vapors sterilizations 15-20 minute or 130 ℃ of following saturated vapors sterilizations 8-15 minute, adopt the method sterilization of irradiation, microwave or gaseous sterilization.
CNB031176143A 2003-04-01 2003-04-01 Medicine for curing prostatosis and its preparation method Ceased CN1235608C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB031176143A CN1235608C (en) 2003-04-01 2003-04-01 Medicine for curing prostatosis and its preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB031176143A CN1235608C (en) 2003-04-01 2003-04-01 Medicine for curing prostatosis and its preparation method

Publications (2)

Publication Number Publication Date
CN1476877A CN1476877A (en) 2004-02-25
CN1235608C true CN1235608C (en) 2006-01-11

Family

ID=34152688

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB031176143A Ceased CN1235608C (en) 2003-04-01 2003-04-01 Medicine for curing prostatosis and its preparation method

Country Status (1)

Country Link
CN (1) CN1235608C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101773542A (en) * 2009-03-30 2010-07-14 贵州太和制药有限公司 Medicine for treating prostatic diseases and preparation method thereof

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101152264B (en) * 2007-10-12 2012-01-25 贵阳春科药业技术研发有限公司 Medicament for treating prostate disease and urinary tract infection and method for preparing the same
CN101804090B (en) * 2010-04-27 2013-02-13 贵州太和制药有限公司 Tablet used for treating prostate diseases as well as preparation method and application thereof
CN104906327A (en) * 2015-06-25 2015-09-16 贵州盛世保康茶开发有限公司 Miao ethnomedicine for treating benign prostatic hyperplasia and preparation method of Miao ethnomedicine
CN109381490A (en) * 2018-11-29 2019-02-26 四川金岁方药业有限公司 A kind of hedgehog skin powder and preparation method thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101773542A (en) * 2009-03-30 2010-07-14 贵州太和制药有限公司 Medicine for treating prostatic diseases and preparation method thereof
CN101773542B (en) * 2009-03-30 2011-11-30 贵州太和制药有限公司 Medicine for treating prostatic diseases and preparation method thereof

Also Published As

Publication number Publication date
CN1476877A (en) 2004-02-25

Similar Documents

Publication Publication Date Title
CN101537107A (en) External use liniment capable of treating dermatomycosis and preparation method thereof
CN1883618A (en) Effective parts of cirald daphne bark, preparation method and application thereof
CN101143171B (en) Traditional Chinese medicine and its preparation method and its application
CN102058707B (en) Chinese medicine paste for treating diaper dermatitis for newborn infants
CN1235608C (en) Medicine for curing prostatosis and its preparation method
CN101439114B (en) Chinese medicine for treating burn and scald, and preparation method thereof
CN101708253B (en) Prickly heat powder
CN1189197C (en) Traditional Chinese medicine having effects of reducing inflammation, stopping blooding, stopping pain, promoting blood circulation and promoting tissue regeneration
CN102600343B (en) Traditional Chinese medicinal preparation for treating oral diseases and/or toothache
CN104645153A (en) Traditional Chinese medicine composition for treating chronic abacterial prostatitis
CN100471512C (en) Medicinal wine for treating rheumatism and rheumatoid disease and its prepn
CN105079332A (en) Traditional Chinese medicine composition for treating perianal abscess caused by fire toxin accumulation
CN100566741C (en) A kind of antipsoriatics thing
CN1228064C (en) Externally appied medicine for relieving pain and diminishing inflammation
CN113332365B (en) Compound lithospermum ointment and preparation method thereof
CN1065137C (en) Liniment made of traditional Chinese medicine for treating pharyngitis, and prepn. method therefor
CN103977296A (en) Traditional Chinese medicine oral solution for treating urethritis and preparation method thereof
CN104857262A (en) Pure Chinese material medicine preparation for treating knife wounds and postoperative pyogenic infection
CN104800735B (en) A kind of Chinese medicine for treating the carcinoma of the rectum
CN1087944C (en) Prescription capsule for removing kidney stone
CN103656317B (en) A kind of Chinese medicine composition for the treatment of hyperplasia of prostate and preparation method thereof
CN104001082A (en) Traditional Chinese medicine for treating damp-heat stasis type kidney calculi
CN103463324B (en) Medicinal composition for preventing or treating oral ulcer and application thereof
CN102626479A (en) External-use Chinese herbal medicine composition for chronic rheumatism treatment
CN103316321B (en) Colitis treatment spray

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
PC01 Cancellation of the registration of the contract for pledge of patent right

Date of cancellation: 20080422

Pledge (preservation): Pledge registration

PE01 Entry into force of the registration of the contract for pledge of patent right

Effective date of registration: 20081125

Pledge (preservation): Pledge

C57 Notification of unclear or unknown address
DD01 Delivery of document by public notice

Addressee: Guo Fang

Document name: Notice of termination

DD01 Delivery of document by public notice

Addressee: Gao Chaoqiong

Document name: Notice of termination

DD01 Delivery of document by public notice

Addressee: Gao Chaoqiong

Document name: Notification of Termination of Procedure

PC01 Cancellation of the registration of the contract for pledge of patent right

Date of cancellation: 20111222

Granted publication date: 20060111

Pledgee: Agricultural Bank of China branch of Xifeng County

Pledgor: Taihe Pharmaceutical Co., Ltd., Guizhou

Registration number: 2008520000491

C35 Partial or whole invalidation of patent or utility model
IW01 Full invalidation of patent right

Decision date of declaring invalidation: 20111014

Decision number of declaring invalidation: 17239

Granted publication date: 20060111